Back to Search
Start Over
Public health responses during measles outbreaks in elimination settings: Strategies and challenges
- Source :
- Human Vaccines & Immunotherapeutics
- Publication Year :
- 2018
- Publisher :
- Informa UK Limited, 2018.
-
Abstract
- In late September 2016, the Americas became the first region in the world to have eliminated endemic transmission of measles virus. Several other countries have also verified measles elimination, and countries in all six World Health Organization regions have adopted measles elimination goals. The public health strategies used to respond to measles outbreaks in elimination settings are thus becoming relevant to more countries. This review highlights the strategies used to limit measles spread in elimination settings: (1) assembly of an outbreak control committee; (2) isolation of measles cases while infectious; (3) exclusion and quarantining of individuals without evidence of immunity; (4) vaccination of susceptible individuals; (5) use of immunoglobulin to prevent measles in exposed susceptible high-risk persons; (6) and maintaining laboratory proficiency for confirmation of measles. Deciding on the extent of containment efforts should be based on the expected benefit of reactive interventions, balanced against the logistical challenges in implementing them.
- Subjects :
- medicine.medical_specialty
Isolation (health care)
Control measures
030231 tropical medicine
Immunology
Psychological intervention
Reviews
Measles
Disease Outbreaks
Measles virus
03 medical and health sciences
elimination
0302 clinical medicine
vaccine
Environmental health
Disease Transmission, Infectious
medicine
Humans
measles
Immunology and Allergy
030212 general & internal medicine
Disease Eradication
Pharmacology
biology
business.industry
Transmission (medicine)
Public health
social distancing
Outbreak
biology.organism_classification
medicine.disease
Vaccination
outbreaks
Communicable Disease Control
Americas
business
immunoglobulin
Subjects
Details
- ISSN :
- 2164554X and 21645515
- Volume :
- 14
- Database :
- OpenAIRE
- Journal :
- Human Vaccines & Immunotherapeutics
- Accession number :
- edsair.doi.dedup.....1d41aeb8f46ef1c06465e113fc556dbf